Syros Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 2.15
| SYRS Stock | USD 0.11 0.01 8.33% |
Syros |
Syros Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Syros Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Syros Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Syros Pharmaceuticals had very high historical volatility over the last 90 days | |
| Syros Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Syros Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.94 M. Net Loss for the year was (164.57 M) with loss before overhead, payroll, taxes, and interest of (88.25 M). | |
| Syros Pharmaceuticals currently holds about 244.48 M in cash with (109.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Syros Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Syros Stock often depends not only on the future outlook of the current and potential Syros Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Syros Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28.3 M | |
| Cash And Short Term Investments | 139.5 M |
Syros Pharmaceuticals Technical Analysis
Syros Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Syros Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Syros Pharmaceuticals. In general, you should focus on analyzing Syros Stock price patterns and their correlations with different microeconomic environments and drivers.
Syros Pharmaceuticals Predictive Forecast Models
Syros Pharmaceuticals' time-series forecasting models is one of many Syros Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Syros Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Syros Pharmaceuticals
Checking the ongoing alerts about Syros Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Syros Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Syros Pharmaceuticals had very high historical volatility over the last 90 days | |
| Syros Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Syros Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.94 M. Net Loss for the year was (164.57 M) with loss before overhead, payroll, taxes, and interest of (88.25 M). | |
| Syros Pharmaceuticals currently holds about 244.48 M in cash with (109.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for Syros Stock Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.